Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ARK Genomic Revolution ETF
(NY:
ARKG
)
38.56
-0.70 (-1.78%)
Official Closing Price
Updated: 8:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ARK Genomic Revolution ETF
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Cathie Wood Sells More Nvidia Shares After Rally: Here's How Many Shares Ark Funds Owns Of AI Giant
↗
June 01, 2023
One of the most notable exchange-traded fund families may have sold shares of Nvidia Corporation (NASDAQ: NVDA) early. The Ark Funds ETFs have continued selling Nvidia shares since the company reported...
Via
Benzinga
Did Cathie Wood's Innovation ARKK ETF Whiff On AI? How It Compares To FAANG, Nvidia In 2023
↗
May 26, 2023
One of the most recognizable investing names of the last decade is Ark Funds CEO Cathie Wood. With an eye on high-growth stocks and innovation, the Ark Funds outperformed the market for years during...
Via
Benzinga
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
↗
April 06, 2023
Via
Benzinga
Cathie Wood Trims Stake In This Chinese E-Commerce Giant – Loads Up On Butterfly Network Stock
↗
April 04, 2023
Via
Benzinga
Move Over, ChatGPT: 5 Stock Ideas For Leveraging The Power Of AI In Health Care, Cybersecurity
↗
April 04, 2023
Generative artificial intelligence has taken the world by storm in 2023.
Via
Benzinga
10 Best Stocks to Buy in March 2023
↗
March 01, 2023
These diversified growth stocks could add rocket fuel to your long-term investment portfolio.
Via
The Motley Fool
Cathie Wood Makes Biggest Coinbase Purchase Of Year After Earnings Beat
↗
February 23, 2023
Cathie Wood and her ARK Invest firm bought $13 million in COIN stock as they bulk up holdings following Coinbase earnings.
Via
Investor's Business Daily
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
↗
February 07, 2023
These stocks are risky. But they just might deliver huge gains if analysts are right.
Via
The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
↗
February 05, 2023
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
Via
Talk Markets
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
↗
January 31, 2023
Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ: HOOD) at
Via
Benzinga
Why Teladoc Stock Popped 5% Today
↗
January 27, 2023
Cathie Wood keeps buying shares of the telemedicine company. Should you?
Via
The Motley Fool
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
↗
January 23, 2023
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.
Via
Talk Markets
Don't Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023
↗
January 23, 2023
The competition could be paying the price in 2023 if Ark Invest can keep up with its early performance at the start of the year.
Via
Benzinga
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
↗
January 17, 2023
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.
Via
Talk Markets
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
↗
January 11, 2023
Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.
Via
Benzinga
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
↗
January 04, 2023
Cathie Wood of ARK Investment Management believes U.S. equity markets are the polar opposite of what they were in the 90s when investors chased their dreams.
Via
Benzinga
War, Inflation, Fed Hawkishness, Elon Musk's Twitter Buy: How These Factors Weighed On Cathie Wood's Top Holdings In 2022
↗
January 02, 2023
In 2022, financial markets witnessed one of the worst routs in history, dragged by the war in Ukraine, rising inflation and subsequent hawkish policies deployed by central banks.
Via
Benzinga
Precious Metals Outperformed Stocks And Bonds In 2022
↗
December 30, 2022
The power of silver's rebound has surprised many, even its most ardent supporters.
Via
Talk Markets
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
↗
December 29, 2022
These two biotechs are flying high right now.
Via
The Motley Fool
'Study The Mindset Of Stonk Hodlers': This Fund Manager Rips Cathie Wood's Investment Strategy
↗
December 22, 2022
ETF fund manager Cathie Wood is known for investing in growth stocks and what she has labeled as “innovation.” A take by the fund manager drew criticism from a hedge fund manager.
Via
Benzinga
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
↗
December 07, 2022
Cathie Wood-led ARK Investment Management bought over 330,000 shares of clinical-stage biotechnology company Verve Therapeutics Inc (NASDAQ: VERV) at an estimated valuation of over $6.9 million, based...
Via
Benzinga
Getting Ready For The Coming Stock Market Elevator Drop
↗
December 04, 2022
In this video Kirk Spano updates trends in Global ETFs and discusses why he thinks stocks are headed down in a big way.
Via
Talk Markets
This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends
↗
November 28, 2022
Congressman Dwight Evans (D-PA) has represented Pennsylvania's Third Congressional District since 2019, and has made over 70 trades in the past three years. His top two traded investments are Intel...
Via
Benzinga
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
↗
November 28, 2022
Here's how Ark Invest's top holdings have performed in 2022.
Via
Investor's Business Daily
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
↗
November 25, 2022
The ARK Invest founder might regret trimming her position in this biotech stock.
Via
The Motley Fool
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
↗
November 22, 2022
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.
Via
Benzinga
Cathie Wood Teams Up With This Investment Bank To Offer Ark Invest's ETFs In Canada
↗
November 19, 2022
Cathie Wood’s Ark Invest, this week, announced a deal with Canadian investment manager BMO Capital Markets.
Via
Benzinga
Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company
↗
October 10, 2022
Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the
Via
Benzinga
ARK Invest Short Sellers Have $2.3B In Profits So Far In 2022
↗
September 30, 2022
After a horrible 2021 for Cathie Wood, the ARK Innovation ETF (NYSE: ARKK) is down another 59.1% in 2022. High-growth tech stocks have taken a beating as interest rates have spiked, sending ARK Invest...
Via
Benzinga
Cathie Wood Sells $2.8M In Healthcare Stock Buoyed By Amazon-Linked Rumors
↗
September 28, 2022
Cathie Wood-led Ark Investment Management on Wednesday sold 96,746 shares of Signify Health Inc. (NYSE: SGFY), estimated to be valued at around $2.8 million.
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit